http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102386464-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 |
| filingDate | 2020-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102386464-B1 |
| titleOfInvention | Composition for Protecting or Treating Non-alcoholic steatohepatitis comprising Exosomes derived from Precursor cell of iPSC-derived mesenchymal stem cell |
| abstract | The present invention relates to a pharmaceutical composition for the prevention or treatment of non-alcoholic steatohepatitis comprising, as an active ingredient, an exosome isolated from induced pluripotent stem cell-derived mesenchymal stem cells that have been pre-treated or not pre-treated with a pre-treatment material. The exosomes of the present invention exhibit a more improved nonalcoholic steatohepatitis prevention or treatment effect compared to the exosomes isolated from existing mesenchymal stem cells, and thus can be usefully used for related research and development and commercialization. |
| priorityDate | 2019-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 562.